Regulation of Renal TNF Production and Function
肾 TNF 产生和功能的调节
基本信息
- 批准号:7372485
- 负责人:
- 金额:$ 39.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAngiotensin IIAntihypertensive AgentsApicalArachidonic AcidsBiologicalBiological AssayBlood PressureCalcineurinCalciumCalcium-Sensing ReceptorsCardiovascular PhysiologyCell NucleusCellsChronicConsumptionCyclosporineDNA Sequence AnalysisDataDevelopmentDiabetes MellitusDinoprostoneDisruptionDominant-Negative MutationExhibitsFibrosisGenesHomeostasisHypercalcemiaHypertensionIon TransportKidneyKidney NeoplasmsLaboratoriesLaser Scanning CytometryLimb structureLinkLipopolysaccharidesMediatingMediator of activation proteinMixed Function OxygenasesModelingMolecularMusNF-ATNa(+)-K(+)-Exchanging ATPaseNatriuresisNephronsOuabainPotassium ChannelProductionProstaglandin-Endoperoxide SynthaseProstaglandinsProtein IsoformsRattusReceptor ActivationRegulationRegulatory PathwayRenal HypertensionRenal functionReporterReportingReverse Transcriptase Polymerase Chain ReactionSodium ChlorideTNFRSF1A geneTestingThickTimeTransfectionTumor Necrosis Factor-alphaVIVIT peptideWaterbasebasolateral membraneblood pressure regulationcell typecyclooxygenase 1cyclooxygenase 2cytokinedesignextracellularhuman TNFRSF1A proteinin vivokidney cortexkidney medullanovelnuclear factors of activated T-cellspressurereceptorresearch studyresponsetumor necrosis factor alpha receptorurinary
项目摘要
DESCRIPTION (provided by applicant): The medullary thick ascending limb (mTAL) is critical to the regulation of salt and water homeostasis and subject to regulation via different monooxygenases that metabolize arachidonic acid. Tumor necrosis factor-alpha (TNF) production is increased in mTAL cells challenged with Angiotensin II (Ang II) and after activation of the calcium-sensing receptor (CaR), and these agonists inhibit ion transport in the mTAL in a TNF- and cyclooxygenase-2 (COX-2)-dependent manner. Thus, the contribution of TNF to prostanoid-dependent mechanisms affecting the regulation of apical K+ channels and Na+-K+-2Cl- cotransporter activity will be determined in mTAL tubules and cells, respectively. Cell will be isolated from wild type littermate control (TNF+/+) and TNF deficient mice. These mice also will be used for in vivo experiments designed to determine the contribution of TNF to the regulation of blood pressure, determined using radiotelemetry, in an Ang II-dependent model of hypertension. The ability of Ang II to regulate COX-2 expression and activity in a TNF-dependent manner also will be determined in vivo. The first demonstration that CaR activation increases nuclear factor of activated T cell (NFAT) activity in any cell type was recently provided by our laboratory. Accordingly, NFAT isoforms present in the mTAL have been identified and will be linked to the production of TNF and PGE2 in mTAL cells after CaR activation. Several cellular and molecular approaches, including electromobility shift assays, laser scanning cytometry, transfection with dominant negative NFAT constructs, and use of NFAT activity reporter constructs, will be used to identify the isoforms that contribute to CaR-mediated TNF production. The biological profile of TNF on cardiovascular function indicates that this cytokine may exhibit either pro- or anti-hypertensive activities in a context-dependent manner. For instance, in mTAL cells, TNF and its relationship to expression of COX-2 and PGE2 may act as part of an antipressor mechanism. Thus, activation of this mechanism in response to extracellular Ca2+ may be initiated by activation of CaR on the basolateral membrane of the TAL, which increases COX-2- derived PGE2 synthesis via a TNF-dependent mechanism. Our findings indicate a mechanism responsible for blood pressure reduction in response to CaR activation by virtue of the inhibitory effect of PGE2 on salt and water transport in the TAL.
描述(由申请人提供):髓质粗升支(mTAL)对盐和水稳态的调节至关重要,并通过代谢花生四烯酸的不同单加氧酶进行调节。在用血管紧张素II(Ang II)激发的mTAL细胞中,钙敏感受体(CaR)激活后,肿瘤坏死因子-α(TNF)的产生增加,这些激动剂以TNF和环氧合酶-2(考克斯-2)依赖性方式抑制mTAL中的离子转运。因此,将分别在mTAL小管和细胞中确定TNF对影响顶端K+通道和Na+-K+-2Cl-共转运蛋白活性调节的前列腺素依赖性机制的贡献。将从野生型同窝对照(TNF+/+)和TNF缺陷小鼠中分离细胞。这些小鼠也将用于体内实验,旨在确定TNF对血压调节的贡献,在Ang II依赖性高血压模型中使用无线电遥测法确定。还将在体内测定Ang II以TNF依赖性方式调节考克斯-2表达和活性的能力。我们的实验室最近首次证明了CaR活化可增加任何细胞类型中活化T细胞核因子(NFAT)的活性。因此,已经鉴定了mTAL中存在的NFAT同种型,并且将其与CaR活化后mTAL细胞中TNF和PGE 2的产生相关联。几种细胞和分子的方法,包括电迁移率变动测定,激光扫描细胞术,转染显性负NFAT结构,和使用NFAT活性报告构建体,将被用来确定的异构体,有助于钙调素介导的TNF生产。TNF对心血管功能的生物学特性表明,这种细胞因子可能以环境依赖性方式表现出促高血压或抗高血压活性。例如,在mTAL细胞中,TNF及其与考克斯-2和PGE 2表达的关系可能作为抗升压机制的一部分。因此,响应于细胞外Ca 2+的该机制的激活可通过TAL的基底外侧膜上的CaR的激活来启动,其通过TNF依赖性机制增加考克斯-2衍生的PGE 2合成。我们的研究结果表明,一种机制,负责血压降低响应CaR激活凭借的抑制作用,PGE 2对盐和水的运输在TAL。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICHOLAS R FERRERI其他文献
NICHOLAS R FERRERI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICHOLAS R FERRERI', 18)}}的其他基金
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10801043 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10296178 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10684910 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha
肿瘤坏死因子-α 对 NKCC2 亚型和血压的调节
- 批准号:
10887848 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Thick ascending limb-derived TNF, salt sensitivity, and blood pressure regulation
厚升肢源性 TNF、盐敏感性和血压调节
- 批准号:
9306934 - 财政年份:2016
- 资助金额:
$ 39.65万 - 项目类别:
Regulation of Renal TNF Production and Function
肾 TNF 产生和功能的调节
- 批准号:
7558316 - 财政年份:2008
- 资助金额:
$ 39.65万 - 项目类别:
Regulation of Renal TNF Production and Function
肾 TNF 产生和功能的调节
- 批准号:
7761680 - 财政年份:2008
- 资助金额:
$ 39.65万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 39.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)